Growth Potential with a Built-in Cushion
Want the growth potential of equity, but with less turbulence along the way? That’s where Bandhan Aggressive Hybrid Fund can help.
The fund invests predominantly in equities to capture growth opportunities, while allocating a portion to debt to provide relative stability. The aim is simple: participate in market upside while maintaining a built-in cushion during periods of volatility.
How to Invest
Consider investing in this fund if you’re…
Looking for equity participation with some downside cushion through a mix of equity and debt
Comfortable with moderate risk in pursuit of long-term capital growth
Seeking a ready asset allocation between equity and debt within a single fund
Performance
Performance based on NAV as on 30/04/2026. Past performance may or may not be sustained in future. For other funds managed by the fund manager, please refer page no. 104 - 112 & the respective fund pages. The performances given are of regular plan growth option. Regular and Direct Plans have different expense structure. Direct Plan shall have a lower expense ratio excluding distribution expenses, commission expenses etc. *Risk-free rate assumed to be 5.34% (FBIL OVERNIGHT MIBOR as on 30th April 2026). Ratios calculated on the basis of 3 years history of monthly data. The portfolio shall be rebalanced on the first business day of every month. #Benchmark Returns. ##Additional Benchmark Returns. If SIP day falls on a non-business day, the SIP transaction shall be processed on the next business day. @Income Distribution and Capital Withdrawal $With effect from 19th March 2025, the name of “Bandhan Hybrid Equity Fund” has changed to “Bandhan Aggressive Hybrid Fund”
Click here
for other funds managed by the fund manager.
Click here
for SIP performance
Product info
Bandhan Aggressive Hybrid Fund
(An Open-ended hybrid scheme investing predominantly in equity and equity related instruments)
This product is suitable for investors who are seeking* :
- To create wealth over long term.
- Investment predominantly in equity and equity related securities and balance exposure in debt and money market instruments.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.